Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as ORL1-receptor antagonists

Details for Australian Patent Application No. 2006257274 (hide)

Owner Pfizer Inc.

Inventors Nakamura, Hiroshi; Matsumoto, Yukari; Koike, Hiroki; Hashizume, Yoshinobu; Hirota, Masako; Mihara, Sachiko

Agent Allens Arthur Robinson

Pub. Number AU-A-2006257274

PCT Pub. Number WO2006/134486

Priority 60/691,939 17.06.05 US

Filing date 9 June 2006

Wipo publication date 21 December 2006

International Classifications

A61K 31/46 (2006.01) - 8-Azabicyclo [3.2.1] octane

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 451/06 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/134486 Priority application(s): WO2006/134486

19 January 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006257281-Acarbose methods and formulations for treating chronic constipation

2006257273-Alpha-(ARyl-Or heteroarylmethyl)-beta-piperidinopropanoic acid compounds as orl1-receptor antagonists